Clinical and bacteriological evaluation of nadifloxacin 1% cream in patients with acne vulgaris: a double-blind, phase III comparison study versus erythromycin 2% cream.

Source:http://linkedlifedata.com/resource/pubmed/id/16436342

Download in:

View as

General Info

PMID
16436342